Lonza
NeuroSense, Lonza Partner to Identify Exosome-Based Neurodegenerative Disease Biomarkers
The collaboration will initially support further development of NeuroSense's lead amyotrophic lateral sclerosis drug candidate, PrimeC.
The collaboration will initially support further development of NeuroSense's lead amyotrophic lateral sclerosis drug candidate, PrimeC.